List of Tables:
Table 1. Snapshot of Asia Pacific Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Pharmacovigilance and Drug Safety Software Market 35
Table 5. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 43
Table 6. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 49
Table 7. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 56
Table 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 63
Table 9. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 67
Table 10. Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 76
Table 11. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 83
Table 12. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 87
Table 13. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 87
Table 14. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 87
Table 15. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 89
Table 16. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 89
Table 17. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 89
Table 18. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 91
Table 19. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 91
Table 20. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 91
Table 21. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 93
Table 22. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 93
Table 23. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 93
Table 24. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 95
Table 25. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 95
Table 26. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 95
Table 27. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn 97
Table 28. Ab Cube: Company Snapshot 102
Table 29. Ab Cube: Business Segmentation 103
Table 30. Ab Cube: Product Portfolio 103
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Asia Pacific Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Pharmacovigilance and Drug Safety Software Market 27
Figure 7. Percentage of Trial Participants by Country, 2015-2019 30
Figure 8. World Drug Discovery Market, 2019-2030, $ mn 31
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Pharmacovigilance and Drug Safety Software Market 32
Figure 10. Investment Opportunity Analysis 36
Figure 11. Porters Fiver Forces Analysis of Asia Pacific Pharmacovigilance and Drug Safety Software Market 39
Figure 12. Breakdown of Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue 44
Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%) 44
Figure 14. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn 45
Figure 15. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn 46
Figure 16. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn 47
Figure 17. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn 48
Figure 18. Breakdown of Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue 50
Figure 19. Asia Pacific Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%) 50
Figure 20. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn 51
Figure 21. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn 52
Figure 22. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn 53
Figure 23. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn 54
Figure 24. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn 55
Figure 25. Breakdown of Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue 57
Figure 26. Asia Pacific Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%) 57
Figure 27. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn 58
Figure 28. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn 59
Figure 29. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn 60
Figure 30. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn 61
Figure 31. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn 62
Figure 32. Breakdown of Asia Pacific Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue 64
Figure 33. Asia Pacific Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%) 64
Figure 34. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn 65
Figure 35. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn 66
Figure 36. Breakdown of Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue 68
Figure 37. Asia Pacific Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 68
Figure 38. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn 69
Figure 39. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn 70
Figure 40. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn 71
Figure 41. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn 72
Figure 42. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn 73
Figure 43. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn 74
Figure 44. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn 75
Figure 45. Breakdown of Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue 76
Figure 46. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 77
Figure 47. Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 78
Figure 48. Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 79
Figure 49. Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn 80
Figure 50. Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn 81
Figure 51. Breakdown of APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 83
Figure 52. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 84
Figure 53. Pharmacovigilance and Drug Safety Software Market in Japan, 2021-2031, $ mn 86
Figure 54. Pharmacovigilance and Drug Safety Software Market in China, 2021-2031, $ mn 88
Figure 55. Pharmacovigilance and Drug Safety Software Market in Australia, 2021-2031, $ mn 90
Figure 56. Pharmacovigilance and Drug Safety Software Market in India, 2021-2031, $ mn 92
Figure 57. Pharmacovigilance and Drug Safety Software Market in South Korea, 2021-2031, $ mn 94
Figure 58. Pharmacovigilance and Drug Safety Software Market in Rest of APAC, 2021-2031, $ mn 96
Figure 59. Growth Stage of Asia Pacific Pharmacovigilance and Drug Safety Software Industry over the Forecast Period 98
